- Home
- HITI vs KOD Comparison
HITI vs KOD Comparison
Compare HITI & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- KOD
- Stock Information
- Founded
- HITI 2009
- KOD 2009
- Country
- HITI Canada
- KOD United States
- Employees
- HITI N/A
- KOD N/A
- Industry
- HITI
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HITI
- KOD Health Care
- Exchange
- HITI Nasdaq
- KOD Nasdaq
- Market Cap
- HITI 178.6M
- KOD 198.4M
- IPO Year
- HITI N/A
- KOD 2018
- Fundamental
- Price
- HITI $3.17
- KOD $8.55
- Analyst Decision
- HITI Strong Buy
- KOD Hold
- Analyst Count
- HITI 2
- KOD 4
- Target Price
- HITI $4.75
- KOD $11.75
- AVG Volume (30 Days)
- HITI 1.0M
- KOD 647.2K
- Earning Date
- HITI 09-15-2025
- KOD 08-13-2025
- Dividend Yield
- HITI N/A
- KOD N/A
- EPS Growth
- HITI N/A
- KOD N/A
- EPS
- HITI N/A
- KOD N/A
- Revenue
- HITI $398,202,371.00
- KOD N/A
- Revenue This Year
- HITI $12.17
- KOD N/A
- Revenue Next Year
- HITI $21.96
- KOD N/A
- P/E Ratio
- HITI N/A
- KOD N/A
- Revenue Growth
- HITI 9.22
- KOD N/A
- 52 Week Low
- HITI $1.64
- KOD $1.92
- 52 Week High
- HITI $3.66
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- HITI 58.22
- KOD 50.31
- Support Level
- HITI $3.33
- KOD $8.29
- Resistance Level
- HITI $3.62
- KOD $9.23
- Average True Range (ATR)
- HITI 0.21
- KOD 0.93
- MACD
- HITI -0.01
- KOD -0.29
- Stochastic Oscillator
- HITI 56.11
- KOD 8.64
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.